Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results
Go back to Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $45.34 | |||
| Open | $3.89 | 52 Week Low | $15.92 | |||
| Day High | $3.89 | P/E | 1.67 | |||
| Day Low | $3.89 | EPS | $2.33 | |||
| Volume | 75 | |||||
